These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 773177)

  • 21. The epidemiology of animal bite injuries in Uganda and projections of the burden of rabies.
    Fèvre EM; Kaboyo RW; Persson V; Edelsten M; Coleman PG; Cleaveland S
    Trop Med Int Health; 2005 Aug; 10(8):790-8. PubMed ID: 16045466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rabies surveillance in the rural population of Cluj County, Romania.
    Bocsan IS; Brumboiu I; Coman A; Tarba R; Zanc V; Mihaiu M
    Rural Remote Health; 2005; 5(3):431. PubMed ID: 16178673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rabies epidemic on Flores Island, Indonesia (1998-2003).
    Windiyaningsih C; Wilde H; Meslin FX; Suroso T; Widarso HS
    J Med Assoc Thai; 2004 Nov; 87(11):1389-93. PubMed ID: 15825719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin.
    Wilde H; Chomchey P; Punyaratabandhu P; Phanupak P; Chutivongse S
    Bull World Health Organ; 1989; 67(6):731-6. PubMed ID: 2633888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human antirabies gamma globulin.
    HOSTY TS; KISSLING RE; SCHAEFFER M; WALLACE GA; DIBBLE EH
    Bull World Health Organ; 1959; 20(6):1111-9. PubMed ID: 14403320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of inactivated tissue culture rabies vaccine in dogs.
    Strating A; Bunn TO; Goff MT; Phillips CE
    J Am Vet Med Assoc; 1975 Nov; 167(9):809-12. PubMed ID: 1237485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine--Thailand.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Nov; 36(46):759-60, 765. PubMed ID: 3118174
    [No Abstract]   [Full Text] [Related]  

  • 30. Current and future trends in the prevention, treatment and control of rabies.
    Rupprecht CE; Willoughby R; Slate D
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):1021-38. PubMed ID: 17181418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and feasibility of purified chick embryo cell vaccine.
    Sehgal S; Bhardwaj M; Bhattacharya D
    Indian Pediatr; 1994 Feb; 31(2):133-7. PubMed ID: 7875835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
    Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
    J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human rabies immune globulin.
    Sikes RK
    Public Health Rep (1896); 1969 Sep; 84(9):797-801. PubMed ID: 4185138
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of human rabies in Yugoslavia].
    Lalosević D; Lalosević V; Petrović R
    Med Pregl; 1998; 51 Suppl 1():25-30. PubMed ID: 9769652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of serum and vaccine in combination for prophylaxis following exposure to rabies.
    Lin FT; Chen SB; Wang YZ; Sun CZ; Zeng FZ; Wang GF
    Rev Infect Dis; 1988; 10 Suppl 4():S766-70. PubMed ID: 3206088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of skin testing for predicting reactions to equine rabies immune globulin.
    Tantawichien T; Benjavongkulchai M; Wilde H; Jaijaroensup W; Siakasem A; Chareonwai S; Yountong C; Sitprija V
    Clin Infect Dis; 1995 Sep; 21(3):660-2. PubMed ID: 8527562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rabies in dogs and efficacy of active immunoprophylaxis in Yugoslavia].
    Stankov S; Lalosević D; Pavlović R; Lalosević V; Knezević N; Budincević I
    Med Pregl; 1998; 51 Suppl 1():43-6. PubMed ID: 9769655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.
    Rupprecht CE; Hanlon CA; Slate D
    Dev Biol (Basel); 2004; 119():173-84. PubMed ID: 15742629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.